Back |
home / stock / adgi / adgi message board
Subject | By | Source | When |
---|---|---|---|
Exactly Bud ;-) $ADGI $$$ | Man6677 | investorshub | 12/22/2021 2:33:35 PM |
I think these MMs know they got a | Outcast27 | investorshub | 12/22/2021 2:03:19 PM |
Good start today , with some good news | Man6677 | investorshub | 12/21/2021 7:46:13 PM |
Which one / ones do you hold | Outcast27 | investorshub | 12/21/2021 3:03:20 PM |
I want to see GREEN here today ;-) | Man6677 | investorshub | 12/21/2021 12:46:41 PM |
I don't like to hold companies like this | Pedro2004 | investorshub | 12/20/2021 4:33:50 PM |
I'm never sure about anything. | Pedro2004 | investorshub | 12/20/2021 4:32:30 PM |
$ADGI - Friday Rundown, Monday Expectations | Jake L | investorshub | 12/18/2021 5:39:20 AM |
Yep, Have a Great weekend...Stay Safe....It's spreading like | Outcast27 | investorshub | 12/17/2021 9:08:00 PM |
The cards will be reshuffled next week ;-) | Man6677 | investorshub | 12/17/2021 9:01:04 PM |
These pricks did it last day dip....This tells | Outcast27 | investorshub | 12/17/2021 8:32:01 PM |
Exactly;-) $ADGI $$$ | Man6677 | investorshub | 12/17/2021 8:27:34 PM |
News, Short Squeeze, Breakout and More Instantly...
Adagio Therapeutics Inc. Company Name:
ADGI Stock Symbol:
NASDAQ Market:
WALTHAM, Mass., May 13, 2024 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that Marc Elia, Chairman of the Invivyd Board of Directors, is scheduled to present in a fireside cha...
Launched PEMGARDA™ in the U.S. for COVID-19 pre-exposure prophylaxis (PrEP) in certain adults and adolescents with moderate-to-severe immune compromise Reported interim exploratory COVID-19 clinical event data from CANOPY Phase 3 clinical trial of VYD222 Received product-sp...
Pathway leverages immunobridging approach via serum virus neutralizing antibody (sVNA) titers enabled by prior successful COVID-19 treatment clinical trial “STAMP” conducted with prototype antibody adintrevimab Company anticipates submitting a COVID-19 treatment EUA applicat...